| PLTR |
Report |
Revenue |
BEAT |
pred ~$1.86B vs. cons $1.80B |
MEDIUM |
| PLTR |
Report |
Adjusted EPS |
BEAT |
pred ~$0.37 vs. cons $0.35 |
MEDIUM |
| PLTR |
Report |
U.S. commercial revenue |
BEAT |
pred ~$0.78B vs. cons $0.75B |
LOW |
| PLTR |
Guide |
FY2026 revenue |
BETTER |
guide ~$7.95B vs. cons $7.88B (FY2026) |
MEDIUM |
| PLTR |
Guide |
FY2026 U.S. commercial revenue |
BETTER |
guide ~$3.45B vs. cons $3.42B (FY2026) |
MEDIUM |
| PLTR |
Guide |
FY2026 adjusted operating income |
BETTER |
guide ~$4.68B vs. cons $4.65B (FY2026) |
LOW |
| PLTR |
Return |
Day-1 residual (stock − beta × S&P 500) |
+5.5% |
— |
MEDIUM |
| PLTR |
Return |
5-day cumulative residual |
+6.5% (FOLLOW-THROUGH) |
Revenue guide ~$7.95B versus ~$7.88B consensus and adjusted operating-income guide ~$4.68B versus ~$4.65B support upward FY2026 and out-period estimate revisions after a ~$1.86B revenue print versus ~$1.80B consensus. |
MEDIUM |